Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study
Open Access
- 13 September 2006
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 17 (12) , 1803-1809
- https://doi.org/10.1093/annonc/mdl312
Abstract
Background: A large variation in the number of nodes examined between patients, hospitals, and regions has been reported for patients with colon cancer. We studied determinants of this variation and its relation to survival in the south of The Netherlands. Patients and methods: All patients who underwent resection for stage I–III colon carcinoma diagnosed from 1999 to 2002 in the Eindhoven Cancer Registry area were included (n = 2168). Determinants of lymph node evaluation and their relationship to survival were assessed, including variation between the six departments of pathology. Results: A median number of six lymph nodes per specimen had been examined. The median number for each department of pathology ranged from three to eight (P < 0.0001). After correction for relevant factors, this variation remained, resulting in differences in the proportion of N+ tumours between departments from 29% to 41% (P < 0.0001). The number of nodes examined was positively associated with survival. Survival for node-negative patients differed between the departments of pathology (up to hazard ratio 1.5; P = 0.02). Conclusion: There was a large variation in lymph node evaluation between the departments of pathology, leading to differences in stage distribution and survival. Intervention strategies should be directed at nodal assessment.Keywords
This publication has 33 references indexed in Scilit:
- Cancer staging and survival in colon cancer is dependent on the quality of the pathologists’ specimen examinationEuropean Journal Of Cancer, 2005
- Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based StudyJNCI Journal of the National Cancer Institute, 2005
- Number of lymph nodes examined and prognosis of TNM stage II colorectal cancerEuropean Journal Of Cancer, 2005
- Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?Journal of Clinical Oncology, 2004
- Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089Journal of Clinical Oncology, 2003
- Guidelines 2000 for Colon and Rectal Cancer SurgeryJNCI Journal of the National Cancer Institute, 2001
- Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution studyGut, 2000
- Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.Journal of Clinical Oncology, 1997
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990